<!DOCTYPE html>
<html lang="en">
<head>
  
  
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    
    
    <link rel="canonical" href="https://jzpero.github.io/mednotes/Critical%20Care/Neuro%20Critical%20Care/Elevated%20ICP/">
    <link rel="shortcut icon" href="../../../img/favicon.ico">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" />
    <title>Elevated Intracranial Pressure - MedNotes</title>
    <link href="../../../css/bootstrap-3.3.7.min.css" rel="stylesheet">
    <link href="../../../css/font-awesome-4.7.0.css" rel="stylesheet">
    <link href="../../../css/base.css" rel="stylesheet">
    <link rel="stylesheet" href="../../../css/highlight.css">
    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->

    <script src="../../../js/jquery-3.2.1.min.js"></script>
    <script src="../../../js/bootstrap-3.3.7.min.js"></script>
    <script src="../../../js/highlight.pack.js"></script>
    
    <base target="_top">
    <script>
      var base_url = '../../..';
      var is_top_frame = false;
        
        var pageToc = [
          {title: "Elevated Intracranial Pressure", url: "#_top", children: [
              {title: "Physiology and Pathophysiology", url: "#physiology-and-pathophysiology" },
              {title: "Causes of ICP Elevation", url: "#causes-of-icp-elevation" },
              {title: "Clinical Manifestations", url: "#clinical-manifestations" },
              {title: "Diagnosis of Elevated ICP", url: "#diagnosis-of-elevated-icp" },
              {title: "Pressure Interpretation", url: "#pressure-interpretation" },
              {title: "Treatment of Elevated ICP", url: "#treatment-of-elevated-icp" },
          ]},
          {title: "ICP Management (2019 SIBICC Algorithm)", url: "#icp-management-2019-sibicc-algorithm", children: [
              {title: "Tier 1 Therapies", url: "#tier-1-therapies" },
              {title: "Tier 2 Therapies", url: "#tier-2-therapies" },
              {title: "Tier 3 Therapies", url: "#tier-3-therapies" },
              {title: "Critical Neuroworsening", url: "#critical-neuroworsening" },
          ]},
          {title: "References", url: "#references", children: [
          ]},
        ];

    </script>
    <script src="../../../js/base.js"></script> 
</head>

<body>
<script>
if (is_top_frame) { $('body').addClass('wm-top-page'); }
</script>



<div class="container-fluid wm-page-content">
  <a name="_top"></a>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../Herniation%20Syndromes/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../Herniation%20Syndromes/" class="btn btn-xs btn-link">
        Herniation Syndromes
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../EEG%20in%20Critical%20Care/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../EEG%20in%20Critical%20Care/" class="btn btn-xs btn-link">
        EEG in Critical Care
      </a>
    </div>
    
  </div>

    

    <h1 id="elevated-intracranial-pressure">Elevated Intracranial Pressure</h1>
<h2 id="physiology-and-pathophysiology">Physiology and Pathophysiology</h2>
<ul>
<li>fixed intracranial volume - 80% brain, 10% blood, 10% CSF</li>
<li>limited compliance of the intracranial compartment beyond a small increase in volume (large increases in pressure for small increases in volume)</li>
<li>CSF is produced in the choroid plexus at a rate of ~20 mL/hr, and passes through the ventricular system, through the arachnoid space, and is reabsorbed by the arachnoid granulations near the apex of the skull</li>
</ul>
<p><img alt="" src="../_attachments/Pasted%20image%2020221230083920.png" /></p>
<h3 id="hydrocephaly">Hydrocephaly</h3>
<ul>
<li><strong>communicating hydrocephaly</strong><ul>
<li>due to imbalance of CSF production and reabsorption, leading to an elevation of pressure throughout the ventricular system and subarachnoid space</li>
<li>due to:<ul>
<li>inadequate removal of CSF by the arachnoid granulations (meningitis, SAH, carcinomatosis, CSVT)</li>
<li>excessive CSF production (choroid plexus papilloma)</li>
</ul>
</li>
<li>imaging findings:<ul>
<li>symmetrical expansion of all ventricles</li>
<li>effacement of cerebral sulci and cisternal compression</li>
</ul>
</li>
<li>treatment: remove CSF anywhere (lumbar drain, intraventricular drain)</li>
</ul>
</li>
<li><strong>noncommunicating/obstructive hydrocephaly</strong><ul>
<li>due to an obstruction in the flow of CSF, leading to <em>localized</em> upstream hydrocephaly</li>
<li>causes:<ul>
<li>obstruction due to IVH or inflammation</li>
<li>mass lesion</li>
</ul>
</li>
<li>imaging findings:<ul>
<li><em>generation of pressure differentials</em> leads to tissue shifts, herniation</li>
<li>acute obstructive hydrocephalus can lead to periventricular interstitial edema</li>
</ul>
</li>
<li>management:<ul>
<li>removal of CSF from upstream of the obstruction (?EVD from lateral ventricle)</li>
<li>removal of CSF from downstream could precipitate herniation by increasing pressure gradients</li>
</ul>
</li>
</ul>
</li>
</ul>
<h3 id="brain-edema">Brain Edema</h3>
<ul>
<li><strong>vasogenic edema</strong> is due to disruption of the blood-brain barrier, with capillary leak<ul>
<li>tends to involve the white matter</li>
<li>diagnostics:<ul>
<li>CT scan - hypoattenuation</li>
<li>MRI - hyperintensity on T2/FLAIR without diffusion restriction, contrast enhancement</li>
<li>LP - elevated CSF protein</li>
</ul>
</li>
<li>causes:<ul>
<li>tumours</li>
<li>infection</li>
<li>inflammation</li>
<li>traumatic tissue damage, hemorrhage</li>
<li>cerebral venous thrombosis</li>
<li>PRES</li>
</ul>
</li>
<li>management:<ul>
<li>many causes are responsive to steroids (e.g. edema due to tumours, infection, inflammation)</li>
<li>osmotherapy efficacy may be limited by BBB disruption</li>
</ul>
</li>
</ul>
</li>
<li><strong>cytotoxic edema</strong> is due to neuronal injury and neuron swelling<ul>
<li>imaging: affects both grey and white matter<ul>
<li>CT: hypoattentuation, ?loss of grey/white junction</li>
<li>MRI: diffusion restriction with hyperintensity on DWI</li>
</ul>
</li>
<li>causes:<ul>
<li>focal ischemic stroke</li>
<li>global hypoxic-ischemic brain injury</li>
<li>acute liver failure</li>
<li>prolonged seizures</li>
</ul>
</li>
<li>management: <em>not responsive to steroid</em></li>
</ul>
</li>
<li><strong>interstitial edema</strong> (hydrostatic edema)<ul>
<li>secondary to obstructive hydrocephalus</li>
<li>imaging will show hydrocephalus with periventricular edema</li>
<li>management: treat hydrocephalus</li>
</ul>
</li>
<li><strong>osmotic cerebral edema</strong><ul>
<li>due to the presence of an osmotic gradient which favours entry of water into the brain</li>
<li>causes<ul>
<li>acute hyponatremia</li>
<li>dialysis disequilibrium syndrome</li>
<li>rebound edema from hyperosmolar therapy</li>
</ul>
</li>
</ul>
</li>
</ul>
<h2 id="causes-of-icp-elevation">Causes of ICP Elevation</h2>
<ol>
<li><strong>Intracranial mass lesion</strong><ol>
<li>Tumour</li>
<li>Hematoma</li>
<li>Abscess or subdural empyema</li>
</ol>
</li>
<li><strong>Cerebral edema</strong><ol>
<li>Focal edema<ol>
<li>Large ischemic stroke</li>
<li>Perihematomal edema</li>
</ol>
</li>
<li>Global edema<ol>
<li>TBI with DAI</li>
<li>Anoxic brain injury</li>
<li>Hyperammonemia</li>
<li>Hyponatremia</li>
<li>Hypercapnia</li>
<li>Hyperthermia</li>
<li>Encephalitis</li>
<li>PRES</li>
<li>Post-carotid endarterectomy hyperperfusion syndrome</li>
</ol>
</li>
</ol>
</li>
<li><strong>Communicating hydrocephalus</strong><ol>
<li>Meningitis</li>
<li>Leptomeningeal carcinomatosis</li>
<li>SAH</li>
<li>Superior sagittal sinus thrombosis</li>
</ol>
</li>
<li><strong>Obstructive hydrocephalus</strong><ol>
<li>Any flow-limiting lesion (extraventricular, intraventricular)</li>
</ol>
</li>
<li><strong>Venous outflow issues</strong><ol>
<li>Cerebral venous sinus thrombosis (CSVT)</li>
<li>Jugular vein compression or thrombosis</li>
<li>External neck compression</li>
<li>SVC syndrome</li>
<li>Severe systemic venous congestion</li>
<li>Thoracic or intra-abdominal compartment syndrome</li>
</ol>
</li>
</ol>
<h2 id="clinical-manifestations">Clinical Manifestations</h2>
<ul>
<li>diffuse elevation of ICP:<ul>
<li>headache (worsened by coughing, sneezing, lying down, exertion)</li>
<li>vomiting (+/- nausea, projectile, and refractory to medical therapy)</li>
<li>altered LOC </li>
<li>visual alterations (vision loss, flashing lights, diplopia)</li>
<li>abducens nerve (CN VI) palsy with lateral gaze palsy</li>
<li>Cushing's triad (hypertension, bradycardia, irregular respirations) which is a late manifestation of severe brain injury -- but isolated hypertension may be seen early</li>
</ul>
</li>
<li><a href="../Herniation%20Syndromes/">Herniation Syndromes</a> (secondary to focal elevation of ICP)
<img alt="" src="../_attachments/Pasted%20image%2020221230090410.png" /></li>
</ul>
<h2 id="diagnosis-of-elevated-icp">Diagnosis of Elevated ICP</h2>
<h3 id="neuroimaging">Neuroimaging</h3>
<p>CT scan performance depends on the cause of ICP elevation. For focal anatomic lesions, it is excellent and can easily detect tissue shifts. For causes of elevated ICP with anatomically normal brains (diffuse processes), the CT scan may be falsely normal. In these cases, consider MRI.</p>
<div class="admonition note">
<p class="admonition-title">Warning</p>
<p>Normal CT imaging doesn't rule out elevated ICP.</p>
</div>
<h3 id="opening-pressure-measurement">Opening Pressure Measurement</h3>
<p>For patients who are lying in a supine position, the opening pressure of the lumbar puncture is a validated measurement of intracranial pressure. <em>Multiply the opening pressure (in cm H2O) by 0.7 to get the mm Hg value.</em></p>
<p>When is LP safe? In the presence of focal pathology, lumbar puncture may be dangerous.  This is particularly true in the case of noncommunicating hydrocephalus or mass lesions with threatened downward herniation. In the absence of a mass lesion or CSF obstruction, lumbar puncture is a safe strategy to measure intracranial pressure.  This may be both diagnostic and therapeutic, since removal of CSF via lumbar puncture will be beneficial among patients with communicating hydrocephalus.</p>
<p>Consider LP in suspected causes of meningitis, pseudotumour cerebri in which CT rules out focal lesions at risk of herniation.</p>
<h3 id="continuous-icp-monitoring">Continuous ICP Monitoring</h3>
<ul>
<li>general indications: <ul>
<li>known or likely to have elevated ICP</li>
<li>poor neurological examination</li>
<li>favourable prognosis + aggressive care goals</li>
<li>certain disease state (TBI) as opposed to others (ischemic stroke)</li>
<li><em>no high quality evidence that ICP monitoring and treatment is beneficial</em></li>
</ul>
</li>
<li>disease-specific indications<ul>
<li>TBI: with GCS &lt;= 8 and CT evidence of hematoma, contusion, swelling, herniation, or compressed basal cisterns</li>
<li>SAH: EVD generally indicated for patients for acute hydrocephalus</li>
</ul>
</li>
<li>techniques<ul>
<li><strong>external ventricular drain (EVD)</strong><ul>
<li>burr hole to penetrate the skull, and blind catheter advancement into the lateral ventricle using landmarks. Bedside procedure.</li>
<li>allows for continuous pressure transduction, CSF sampling, therapeutic drainage</li>
<li>the most accurate but most invasive form of ICP monitoring</li>
<li>complications: 10% develop ventriculitis, there can be some trauma from the blind insertion through brain tissue</li>
</ul>
</li>
<li><strong>Intraparenchymal monitor</strong><ul>
<li>less invasive, lower infeciton rate</li>
<li>cannot sample CSF for diagnostic or therapeutic purposes</li>
<li>localized pressure may not reflect general ICP</li>
<li>measurements tend to drift, and re-calibration is not possible</li>
</ul>
</li>
</ul>
</li>
</ul>
<h2 id="pressure-interpretation">Pressure Interpretation</h2>
<h3 id="icp">ICP</h3>
<ul>
<li><strong>Normal ICP is 5-15 mmHg (8-20 cm H2O)</strong>. 1 cm of water equals 0.74 mm of mercury (Hg).</li>
<li>Sustained (&gt;10-15 minutes) levels &gt;20-22 mmHg are an indication for ICP targeted therapy ("ICP crisis")<ul>
<li>Transient elevations should not trigger intervention</li>
<li>important to take into context other factors:<ul>
<li>absolute value</li>
<li>ICP waveform</li>
<li>cerebral perfusion pressure</li>
<li>clinical context</li>
</ul>
</li>
</ul>
</li>
</ul>
<h4 id="icp-waveform-analysis">ICP Waveform Analysis</h4>
<ul>
<li>Three waves (P1, 2, 3). Normally P1 &gt; P2 &gt; P3 in descending pattern (see below).<ul>
<li>P1 percussion wave - reflections off choroid plexus</li>
<li>P2 tidal wave - brain compliance</li>
<li>P3 dicrotic wave - aortic valve closure</li>
</ul>
</li>
<li>As ICP elevates, brain compliance is compromised and P2 becomes higher than P1 and can eventually fuse together into P1-2</li>
<li>Abnormal ICP waveforms can precede absolute ICP elevations.</li>
</ul>
<p><img alt="" src="../_attachments/Pasted%20image%2020221230094904.png" />
<img alt="" src="../_attachments/Pasted%20image%2020221230094913.png" /></p>
<h4 id="plateau-waves">PLateau waves</h4>
<ul>
<li>defined as "pathological A waves": transient, periodic severe elevations in ICP (up to 50-100 mm Hg) usually lasting for 5-30 minutes.<ul>
<li>they can occur spontaneously, or can be precipitated by coughing, pain, changes in position</li>
<li>often accompanied by clinical deterioration and symptoms<ul>
<li>pupillary dilatation</li>
<li>reduced consciousness</li>
<li>ataxia, posturing</li>
<li>headaches, nausea, vomiting</li>
<li>visual loss</li>
</ul>
</li>
</ul>
</li>
<li>due to a spiral of ICP elevation, reduced CPP, cerebral vasodilation: <img alt="" src="../_attachments/Pasted%20image%2020221230095415.png" /></li>
<li>can be mistaken for other phenomena<ul>
<li>seizures</li>
<li>orthostatic hypotension</li>
</ul>
</li>
<li>generally self-resolve, but episodes &gt;30 minutes can lead to irreversible damage due to impaired perfusion</li>
<li>can be terminated by interventions that cause cerebral vasoconstriction (hyperventilation, vasopressors that induce hypertension)</li>
</ul>
<p><img alt="" src="../_attachments/Pasted%20image%2020221230095445.png" />
<img alt="" src="../_attachments/Pasted%20image%2020221230095500.png" /></p>
<h3 id="cerebral-perfusion-pressure">Cerebral Perfusion Pressure</h3>
<p>$$ CPP = (MAP - ICP) $$
- The CPP is the driving pressure for bloodflow through the brain. A <strong>normal CPP is 50-90 mm Hg</strong>, and should be maintained above &gt;60 mmHg.
- Cerebral autoregulation will maintain a stable cerebral blood flow across a wide range of CPP values (e.g., ~50-140 mm). However, <em>an injured brain may lose autoregulatory capacity</em> leading to increased blood flow in response to elevated CPP.
- possible that obtaining an adequate CPP is is more important that a normal ICP. Ideally maintain CPP &gt;60 mm Hg
    - vasopressors w/ arterial MAP monitoring (arterial catheter needs to be calibrate to level of tragus)
    - For patients with ICP elevation whose precise ICP is unknown, it may be reasonable to target a higher Bp than normal (e.g., target MAP &gt;75-80 mm).</p>
<p><img alt="" src="../_attachments/Pasted%20image%2020221230094416.png" /></p>
<h2 id="treatment-of-elevated-icp">Treatment of Elevated ICP</h2>
<h3 id="treat-the-underlying-disorder">Treat the underlying disorder</h3>
<ul>
<li>resect the tumour</li>
<li>manage metabolic disorders</li>
<li>VP shunt for patients with refractory hydrocephalus</li>
<li>?steroids for vasogenic edema</li>
</ul>
<h3 id="basic-measures-for-all-neuro-crit-patients">Basic Measures (for all neuro-crit patients)</h3>
<ul>
<li><strong>avoid excess intrathoracic pressure</strong> by providing adequate sedation and analgesia, avoid coughing and ventilatory asynchrony; avoid excessively elevated airway pressures/PEEP</li>
<li><strong>avoid compression of the jugular veins</strong> by keeping the head in neutral position, avoid a C-collar, and avoid IJV CVCs if possible (i.e. first line subclavian or femoral placement)</li>
<li><strong>target normocapnia</strong><ul>
<li>decreasing PaCO2 causes vasoconstriction of cerebral arteries leading to decreased ICP but also reduced blood flow. Therefore, hyperventilation (PaCO2 25-30 mmHg) should only be used as a short-term bridge to immediate NSx intervention, otherwise it can lead to cerebral hypoperfusion, secondary ischemic injury, and worsening cerebral edema in the long term</li>
<li>monitor CO2 levels closely with a combination of ETCO2 and blood gases</li>
<li><em>for most patients, a reasonable target is a low-normal PaCO2 of 35-40 mmHg</em></li>
</ul>
</li>
<li><strong>target normonatremia</strong>. Target a normal sodium level, and avoid any large and rapid decreases in Na. Avoid hypotonic fluid infusions.</li>
<li><strong>target normothermia</strong>. Fevers increase cerebral metabolic demands and need for arterial perfusion. Consider routine Tylenol, external cooling devices, etc.</li>
<li>elevate HOB?? -- does reduce ICP, but also arterial cerebral perfusion. One study found this reduced CPP and increased plateau waves. Do not exceed 45 degrees HOB elevation.</li>
</ul>
<h3 id="osmotherapy">Osmotherapy</h3>
<ul>
<li>unclear indications: consider for worsening despite conservative best practices with normonatremia.</li>
<li>Agents: Undiluted (1 mEq/mL) sodium bicarbonate which is the same tonicity as 6% saline (2-3 ampules as emergency therapy), 3% hypertonic saline bolus, 23.4% saline, hypertonic sodium acetate</li>
<li>Clinical end-points<ul>
<li>Keep sodium &lt; 155 mEq/L</li>
<li>Avoid NAGMA and/or hyperchloremia (&gt;110-115 mEq/L)</li>
<li>Avoid increases in sodium by more than 6-8 mEq/day to avoid ODS</li>
<li>Avoid volume overload (may have to use diuretics as well)</li>
</ul>
</li>
<li>May have to <em>taper off hypersomolar therapy</em> as everything that goes up must come down.  Increasing the patient's sodium may cause a transient improvement in ICP, but eventually the sodium will need to be lowered back to normal.  Unfortunately, the brain tissue will rapidly adapt to being hypernatremic, so lowering the sodium back to normal carries a risk of rebound ICP elevation.<ul>
<li>do this if the sodium has been elevated for more than 1-2 days</li>
</ul>
</li>
</ul>
<h4 id="mannitol">Mannitol</h4>
<ul>
<li>nephrotoxic, and induces a diuresis. Requires close serum osmolality monitoring</li>
<li>can cause rebound ICP elevation as mannitol crosses the BBB and can cause vasogenic edema</li>
<li>less effective than HTS and causes more AKI, and potentially more mortality than HTS</li>
<li>HTS is recommended in guidelines over mannitol for TBI or ICH</li>
</ul>
<div class="admonition note">
<p class="admonition-title">Mannitol</p>
<p>Overall, do not use mannitol routinely. Strongly consider 3% hypertonic saline over this if possible (also in accordance with guidelines).</p>
</div>
<h3 id="sedation">Sedation</h3>
<ul>
<li>Consider a deeper sedation approach to avoid coughing, ventilatory dyssynchrony. Avoid suctioning if possible. Add PRN opioids. Temporary paralysis with refractory coughing or dyssynchrony.</li>
<li>Use propofol as it reduces brain metabolic activity and is easily titratable</li>
</ul>
<h3 id="seizure">Seizure</h3>
<ul>
<li>If the patient is worsening, rule out NCSE (consider EEG).</li>
<li>consider seizure prophylaxis in certain contexts (specific brain injuries)</li>
</ul>
<h3 id="neurosurgical-intervention">Neurosurgical Intervention</h3>
<ul>
<li>Hydrocephalus --&gt; EVD</li>
<li>Refractory elevated ICP can be treated with decompressive craniectomy. Evidence is best for younger patients with large strokes involving the middle cerebral artery (i.e. <em>malignant MCA syndrome</em>)</li>
</ul>
<h3 id="compartment-pressure-management">Compartment Pressure Management</h3>
<p><img alt="" src="../_attachments/Pasted%20image%2020221230101915.png" />
- intrathoracic pressure management as above
- treat abdominal compartment syndrome if present</p>
<h1 id="icp-management-2019-sibicc-algorithm">ICP Management (2019 SIBICC Algorithm)</h1>
<p><img alt="" src="../_attachments/Pasted%20image%2020230603173415.png" /></p>
<p><img alt="" src="../_attachments/Pasted%20image%2020230603173646.png" /></p>
<p><img alt="" src="../_attachments/Pasted%20image%2020230603173721.png" /></p>
<h2 id="tier-1-therapies">Tier 1 Therapies</h2>
<ol>
<li>CPP 60-70 mmHg</li>
<li>Increased analgosedation</li>
<li>Mild hyperventilation (PaCO2 35-38 mmHg)</li>
<li>Intermittent bolus mannitol/HTS (limiting Na &lt; 155 and Osm &lt; 320 mEq/L)</li>
<li>CSF drainage through existing EVD</li>
<li>1 week of anti-seizure medication</li>
</ol>
<h2 id="tier-2-therapies">Tier 2 Therapies</h2>
<ol>
<li>Mild hyperventilation PaCO2 32-35 mmHg</li>
<li>Trial of neuromuscular paralysis</li>
<li>Trial of MAP increase 10 mmHg</li>
</ol>
<h2 id="tier-3-therapies">Tier 3 Therapies</h2>
<ol>
<li>Pentobarbital or thiopentone trial, and if effective, coma</li>
<li>secondary decompressive craniectomy</li>
<li>Hypohypothermia (35-36 ℃)</li>
</ol>
<h2 id="critical-neuroworsening">Critical Neuroworsening</h2>
<p><img alt="" src="../_attachments/Pasted%20image%2020230603174258.png" /></p>
<h1 id="references">References</h1>
<ol>
<li><a href="https://emcrit.org/ibcc/icp/">Elevated intracranial pressure (ICP) - EMCrit Project</a></li>
</ol>

  <br>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../Herniation%20Syndromes/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../Herniation%20Syndromes/" class="btn btn-xs btn-link">
        Herniation Syndromes
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../EEG%20in%20Critical%20Care/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../EEG%20in%20Critical%20Care/" class="btn btn-xs btn-link">
        EEG in Critical Care
      </a>
    </div>
    
  </div>

    <br>
</div>

<footer class="container-fluid wm-page-content">
  <p>Documentation built with <a href="https://www.mkdocs.org/">MkDocs</a> using <a href="https://github.com/gristlabs/mkdocs-windmill">Windmill</a> theme by Grist Labs.</p>
</footer>

</body>
</html>